Project Grant R01MH141088
- The National Institute of Mental Health awarded the University of California, San Diego $2.115 million on August 1, 2026, under the Mental Health Research Grants program (CFDA 93.242) to develop and evaluate a mobile health system delivering just-in-time adaptive interventions based on dialectical behavior therapy principles for young adults with comorbid major depressive disorder, social anxiety disorder, generalized anxiety disorder, and related anxiety conditions. The UNDERSTAND project...
- The National Institute of Mental Health awarded The Trustees of Princeton University $152,600 under the Mental Health Research Grants program (CFDA 93.242) on November 1, 2026, to conduct neural decoding research on biases in latent cause inference during fear extinction in anxiety disorders. The research leverages computational frameworks and neural decoding from optically-pumped magnetoencephalography (OPM-MEG) in combination with physiological markers including skin conductance response and...
- The National Institute of Mental Health awarded the University of Southern California $751,034 on August 6, 2026, under the Mental Health Research Grants program (CFDA 93.242) to support a neuroscience research project examining how the brain processes uncertainty in noisy, dynamically changing environments. The project, titled "Unraveling Neural Mechanisms Underlying Learning in a Noisy, Dynamically Changing World," investigates computational and neural mechanisms by which the brain...
- The National Institute of Mental Health awarded the University of California, San Diego $1,553,622 on August 1, 2026, under the Mental Health Research Grants program (CFDA 93.242) to conduct a confirmatory efficacy trial of gamma EEG-neurofeedback treatment targeting working memory deficits in individuals with schizophrenia. The award funds a randomized clinical trial designed to confirm efficacy of a neuromodulation intervention that uses real-time EEG neurofeedback to increase synchronous...
- The National Institute of Mental Health awarded the University of Massachusetts Medical School $612,425 on March 15, 2026, under the Mental Health Research Grants program (CFDA 93.242) to conduct longitudinal imaging research on visual discrimination and anxiety in children. The project investigates how high trait anxiety in children is associated with threat misattribution—the tendency to perceive nonthreatening stimuli, particularly faces, as threatening. The research focuses on the...
- The National Institute of Mental Health awarded The Washington University $103,310 on August 3, 2026, under the Mental Health Research Grants program (CFDA 93.242, K99MH144521) to investigate the causal dynamics of human amygdala-prefrontal circuits during fear extinction learning. The recipient will conduct intracranial electrophysiology and neuromodulation research using clinically indicated stereoelectroencephalography electrodes implanted in epilepsy patients undergoing SEEG monitoring....
- The National Institute of Mental Health awarded The Trustees of The University of Pennsylvania $762,440 on April 1, 2026, under the Mental Health Research Grants program (CFDA 93.242) to develop and validate a concurrent transcranial magnetic stimulation and functional MRI protocol for measuring the effects of continuous theta burst stimulation to the right dorsolateral prefrontal cortex on anxiety-related neural and behavioral responses. The protocol will assess TMS-evoked BOLD responses and...
- The National Institute of Mental Health awarded the University of Texas at Austin $234,504 on August 20, 2026, under the Mental Health Research Grants program (CFDA 93.242) to conduct research on contextual modulation of fear and extinction using immersive virtual reality. The research investigates how emotional and environmental contexts shape threat acquisition and extinction learning in humans, with the aim of informing strategies to enhance anxiety disorder treatment efficacy and reduce...
- The National Institute of Mental Health awarded the University of Miami $731,258 on March 1, 2026, under the Mental Health Research Grants program (CFDA 93.242) to map neural dynamics linked to major depressive disorder and generalized anxiety disorder using high-stakes real-world events. The recipient will conduct fMRI neuroimaging across five sessions with 144 undergraduate participants—72 diagnosed with GAD or MDD and 72 controls—leveraging naturally occurring emotional events during...
- The National Institute of Mental Health awarded the Trustees of Indiana University $436,006 on September 1, 2026, to investigate circuit operation underlying fear memory processes in the amygdala under the Mental Health Research Grants program (CFDA 93.242). The award funds research into the neural mechanisms regulating defensive behaviors and fear memory formation in the amygdala. Current models posit that the lateral amygdala serves as the primary input site for sensory information during fear...
The National Institute of Mental Health, part of the Department of Health and Human Services, awarded the University of California, San Diego $684,740 on September 1, 2026, under the Mental Health Research Grants program (CFDA 93.242) to investigate neurocognitive mechanisms underlying fear extinction learning and to test whether computer-based working memory training enhances exposure-based treatment for anxiety disorders. The research will examine whether working memory training administered prior to massed exposure therapy improves fear learning outcomes compared to sham training followed by massed exposure, using public speaking anxiety as a clinical model. The study employs a rigorous experimental trial design to test the hypothesis that enhancing working memory—a neurocognitive process associated with successful fear extinction—may improve exposure therapy efficacy. Computer-based working memory training offers high mechanistic precision, ease of administration, and low cost relative to other neurocognitive enhancement approaches. The long-term goal is to develop improved interventions for anxiety disorders by clarifying the neurocognitive processes involved in exposure-based fear extinction learning, potentially addressing treatment failure in individuals who do not achieve adequate response to standard exposure therapy. Performance occurs in La Jolla, California. The award period extends from September 1, 2026, to June 30, 2031. The assistance type is Project Grant.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $684.7k | 8/27/26 |